Highlights
A collection of news and information related to Drugs and Medicines published by this site and its partners.
Displaying items 1-12 of 10965
» View courant.com items only
1
2
3
4
5
6
7
8
9
10
11-914
•
Next >
-
Succeeding the Adderall Way
With final exams within sight, this excellent rollercoaster of a piece is a must-read for parents of overloaded kids. What I found most interesting was not so much how the writer became addicted to Adderall, but how quickly she responded to a friend&...Tags: Adderall (drug)
-
Plan B Burger Bar Tapped For Inc. Magazine's 'Hire Power Award'
Plan B Burger Bar's recent expansion has caught the eye of Inc. Magazine once again. The publication has honored the company's hiring efforts with an inaugural Hire Power award, which salutes American job creators. The better-burger chain, with six...
Tags: Glastonbury, Plan B (drug), Hamburgers, Newspaper and Magazine, Foods and Beverages
-
Black Friday Brunch at Plan B Milford Nov. 23
If you're shopping in the Milford area early on Black Friday, Plan B is open from 8 a.m. to 11 a.m. for your brunch needs. The special menu includes a bourbon pancakes and eggs bar ($10,) with fixings: bacon and sausage, bourbon maple syrup, powdered...
Tags: Plan B (drug), Dining and Drinking, Brunch, Bars and Clubs, Hurricane Sandy (2012)
-
|Story
Tags: Science and Technology, Crimes, Hospitals and Clinics, Pharmaceuticals, Vehicles
-
Hopkins' global health grade: good, but not good enough
Remember the last time you got a B in a class? Maybe a B was OK, a hard-earned accomplishment in a difficult, GPA-sinking course. Or perhaps a B just wasn't good enough — a subpar finish that left you mentally shaking a fist at other classmates....
Tags: Science and Technology, Education, Medical Research, HIV, Colleges and Universities
-
Importance of expiration date depends on the specific drug
Q: I have several medications that are well beyond their expiration dates. Does that mean that they won't work — or are dangerous? A: The manufacturer's expiration date on most medications is 2-3 years from when the pills were made. This assumes...Tags: Boston, Epinephrine, Pharmaceuticals, Chemical Industry, Harvard Medical School
-
U.S. RESEARCH ROUNDUP: Microsoft, ICE, Actavis, Boeing
ReutersMay 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Actavis, and Microsoft, on Tuesday. HIGHLIGHTS * Microsoft Corp : Janney, UBS raise price target on stock * Boeing : UBS...Tags: LinkedIn Corp., Deutsche Bank AG, Blackrock Inc, Regeneron Pharmaceuticals Incorporated, Semtech Corporation
-
Which Do We Spend More On, Alcohol Or Pets?
The Hartford Courant"There are about 218 million pets in the United States, not counting several million fish." This rather deadpan accounting begins a recent release from the federal government that estimates how much we spend on our dogs, cats, rabbits, hamsters,...Tags: Pets
-
AcelRX post-op pain treatment meets late-stage study goal
Reuters(Reuters) - AcelRX Pharmaceuticals Inc said its experimental treatment for post-operative pain met its main goal in a late-stage trial of patients who had undergone knee or hip replacement surgery, sending its shares up 15 percent. AcelRX said its...Tags: Hip Replacement, Food and Drug Administration, Placebo, Trials
-
PRESS DIGEST-Canada-May 21
ReutersMay 21 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy. THE GLOBE AND MAIL * When Toronto city council meets Tuesday morning to formally...Tags: Wildlife, Pacific Alliance Corporation, Petroleum Industry, Cocaine, Stephen Harper
-
Intercell vaccine gets U.S. pediatric approval
ReutersVIENNA (Reuters) - Austria's Intercell said on Tuesday it has won U.S. regulatory approval for pediatric use of its Ixiaro vaccine to protect against Japanese Encephalitis (JE), a step it had achieved in Europe in February. "For the first time in...Tags: Disease Prevention, Vaccines, Austria, Preventative Medicine
-
XenoPort to drop multiple sclerosis drug, shares fall
Reuters(Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo. Shares of the company fell 26 percent...Tags: GlaxoSmithKline PLC, Trials, Biogen Idec Incorporated, Acorda Therapeutics Incorporated, Conservation
Mar 4, 2013
|Column| ctnow.com
Dec 5, 2012
|Column| ctnow.com
Nov 19, 2012
|Column| ctnow.com
Mar 18, 2010
|Story| Associated Press
May 21, 2013
|Story| Baltimore Sun
May 21, 2013
|Story| South Florida Sun-Sentinel
May 21, 2013
|Story| Reuters
May 21, 2013
|Story| Hartford Courant
May 21, 2013
|Story| Reuters
May 21, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
Original site for Drugs and Medicines topic gallery.
